EClinCloud at SAPA-China 2026 | Overcoming CNS Clinical Endpoint Assessment Challenges

Source: EClinCloud. Author: EClinCloud.
Neurodegenerative diseases such as AD and PD are typically progressive and carry a heavy disease burden. As numerous clinical trials continue to advance globally, accurately identifying drug efficacy through scientifically reliable endpoint assessment has become a major challenge in CNS clinical trials.
Currently, standardizing the administration of rating scale assessments and managing their data quality are challenging, imaging assessments place high demands on standardized reading and quality control, and factors such as poor patient compliance all affect the reliability of endpoint assessment, data integrity, and the interpretability of trial results.
Against this backdrop, EClinCloud will deliver a keynote presentation at the SAPA-China 2026 Pharmaceutical Industry Conference · CNS Forum, sharing experience on the challenges and practices of endpoint assessment in CNS clinical trials.

Event Information
SAPA-China 2026
Presentation Information
EClinCloud at the Forum
CNS Forum
Presentation Topic
Pain Points and Solutions for Endpoint Assessment in Central Nervous System Disease Clinical Research
Presentation Time
Friday, October 30, 2026, 9:50–10:15
Venue
Heshan Hall, Suzhou Shishan International Conference Center
Full Agenda
![]() |
Speaker

Zheng Liangyan
Medical Director, EClinCloud
Previously a chief physician in neurology with nearly 30 years of clinical diagnosis and treatment experience in neurology and extensive experience in university teaching and scientific research. Deeply engaged in clinical research, Zheng has served as a principal investigator (PI) and core research team member across multiple domestic and international multicenter clinical trials, and has completed visiting fellowships at Harvard University's McLean Hospital and the University of Siena Hospital in Italy, bringing extensive international academic exchange experience. At EClinCloud, Zheng focuses on supporting clinical research and medical operations with specialized medical expertise.
We invite you to register for the conference and connect with us on-site

*Conference Schedule (Click to View)
EClinCloud is a leading AI company in the clinical research industry. Driven by AI, it builds an integrated clinical intelligence cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, along with scale management, linguistic validation, rater training, and data quality analysis services. By delivering efficient, precise digital solutions and leveraging AI predictive models and an intelligent data platform, EClinCloud dynamically assesses and helps improve the success rate of drug clinical trials, helping shorten drug and medical device development cycles to benefit patients.




